{ "ok": true, "cik": "1160420", "ticker": "ADIA", "name": "ADIA NUTRITION, INC.", "filings": [ { "form": "8-K", "filed": "2026-10-06", "items": [ "1.01 Entry into a Material Definitive Agreement", "2.01 Completion of Acquisition or Disposition of Assets", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1160420/000168316826007632/0001683168-26-007632-index.htm" }, { "form": "8-K", "filed": "2026-10-05", "items": [ "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1160420/000168316826007624/0001683168-26-007624-index.htm" }, { "form": "8-K", "filed": "2026-08-24", "items": [ "1.01 Entry into a Material Definitive Agreement", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1160420/000168316826006679/0001683168-26-006679-index.htm" }, { "form": "8-K", "filed": "2026-08-17", "items": [ "5.03 Amendments to Articles or Bylaws; Change in Fiscal Year", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1160420/000168316826006525/0001683168-26-006525-index.htm" }, { "form": "10-Q", "filed": "2026-08-13", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1160420/000168316826006313/0001683168-26-006313-index.htm" }, { "form": "10-Q", "filed": "2026-05-15", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1160420/000168316826003957/0001683168-26-003957-index.htm" } ], "events12m": 4, "healthWatch": { "window": "last 12 months", "since": "2025-10-07", "signals": [], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001160420.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1160420" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up ADIA NUTRITION, INC. ($ADIA). Last filing: 8-K (1.01 Entry into a Material Definitive Agreement), 2026-10-06. 4 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 700508, "revenueGrowth1y": 108.79749216300941, "revenueGrowthPerYear": null, "yearsOfData": 2, "operatingMargin": -0.5231803205673596, "operatingMarginPrior": -27.39012539184953, "netMargin": -0.5645388775003284, "operatingCashFlow": -179228, "capitalSpending": 13200, "freeCashFlow": -192428, "researchAndDevelopment": 29144, "researchShareOfRevenue": 0.041604093029629925, "cash": 79392, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2024-12-31", "revenue": 6380 }, { "fiscalYearEnd": "2025-12-31", "revenue": 700508 } ], "totalEquity": -257674, "totalAssets": 594826, "equityRatio": -0.4331922276430418, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 0, "sharesOutstanding": 93596730, "bookValuePerShare": -0.0027530235297750253, "revenuePerShare": 0.007484321300541162, "range80": { "low": 56447200.48168802, "high": 101357297.71735725, "baseline": 76914021.6401254, "n": 749, "band": "b00" }, "ifPaceHeld": { "low": 56447200.48168802, "high": 101357297.71735725 } }, "edgarette": "🔖 Exposure: revenue $701K (FY2025). Experience: revenue up 10879.7% on the year; operating margin -52.3%, up from -2739.0%. Soundness: equity -43.3% of assets (liabilities exceed assets). Credibility: 2 audited years, moderate weight. Range: 80% of past cases like this landed between $56.4M and $101.4M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, medicinal chemicals & botanical products): operating margin -52.3% against a 0.7% median; growth 10879.7% against 1.7%.", "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "summary": "Adia Nutrition (ADIA) grew revenue 10880% in FY2025 to $1 million, operating margin -52.3% against a 0.7% median for medicinal chemicals & botanical products, equity -43.3% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
ADIA NUTRITION, INC. against its own record and its peers
Operating marginPeer median 0.7%-52.3%Revenue, on the yearPeer median 1.7%10879.7%Equity of assetsPeer median 33.3%-43.3%Gold tick: the median of 8–8 peers with $50M+ revenue in medicinal chemicals & botanical products
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-10-07T14:25:39.334Z", "hash": "4719283f8822fb48", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Adia Nutrition (ADIA) grew revenue 10880% in FY2025 to $1 million, operating margin -52.3% against a 0.7% median for medicinal chemicals & botanical products, equity -43.3% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 700508, "totalDebt": null, "cash": 79392 }, "experience": { "revenueGrowth1y": 108.79749216300941, "revenueGrowthPerYear": null, "operatingMargin": -0.5231803205673596, "operatingMarginPrior": -27.39012539184953, "netMargin": -0.5645388775003284, "freeCashFlow": -192428 }, "soundness": { "equityRatio": -0.4331922276430418, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "credibility": { "auditedYears": 2, "weight": "moderate", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-10-07", "signals": [], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 56447200.48168802, "high": 101357297.71735725, "baseline": 76914021.6401254, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 749, "sizeBand": "b00" }, "credibility": null, "stress": null, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-10-07T14:25:39.334Z", "hash": "4719283f8822fb48", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001160420.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1160420" }, "speedCash": null, "harbor": { "signs": [ { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "cash", "text": "operating cash flow was negative (-$179K in FY2025)" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±28%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 3, "name": "Old boat", "plain": "three warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -179228, "investing": -32051, "financing": 284348, "capitalSpending": 13200, "free": -192428, "trend": [ { "fiscalYearEnd": "2024-12-31", "operating": -335476, "free": -357307 }, { "fiscalYearEnd": "2025-12-31", "operating": -179228, "free": -192428 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 79392, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 594826, "ladder": null, "currentRatio": 1.11, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": null, "harbor": { "signs": [ { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "cash", "text": "operating cash flow was negative (-$179K in FY2025)" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±28%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 3, "name": "Old boat", "plain": "three warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -179228, "investing": -32051, "financing": 284348, "capitalSpending": 13200, "free": -192428, "trend": [ { "fiscalYearEnd": "2024-12-31", "operating": -335476, "free": -357307 }, { "fiscalYearEnd": "2025-12-31", "operating": -179228, "free": -192428 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 79392, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 594826, "ladder": null, "currentRatio": 1.11, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." }, "disclaimer": "Data & Disclosure Notice: Edgar and Edgarette are automated software. Every figure on this page is calculated by software from public filings made by companies and funds with the U.S. Securities and Exchange Commission (EDGAR) and is published without individual human review. The accuracy and completeness of those filings are the responsibility of the filers; reports can contain errors and can be amended. Figures are shown as filed and as of each filing's date, and this page may be corrected or updated without notice. Ranges, expected returns, rankings, boats and other measures are statistical descriptions of past filings, not ratings, price forecasts, company guidance or recommendations; past results do not guarantee future results. This is general information published for all readers, not advice tailored to any person's portfolio, needs or circumstances, and nothing here is financial, investment, actuarial, legal, tax or other professional advice. Actuaries and other professionals who use these figures remain responsible for reviewing them for reasonableness and consistency against the original filings and for disclosing their reliance on them. No company, fund or reinsurer pays to be included or ranked. Provided as is, without warranty of any kind. Not affiliated with or endorsed by the SEC or by any company, fund or reinsurer named. All trademarks remain the property of their owners." }